title: FDG-PET imaging in the diagnosis of HIV-associated multicentric Castleman disease: something is still missing.
abstract: Now that [18F] fluorodeoxyglucose positron emission tomography (FDG-PET) has become an established imaging tool in oncology, it is attracting interest in the field of infectious diseases. Several studies have used FDG-PET to examine the pathophysiology of HIV infection as well as other conditions such as lipodystrophic syndrome and HIV-related neurocognitive disorders. In clinical practice, FDG-PET has been proposed to assess fever of unknown origin or with lymphoproliferative disorders such as Castleman disease in individuals with HIV infection.
authors.affiliation: Niguarda Cà Granda Hospital, Milan, Italy. roberto.rossotti@ospedaleniguarda.it
authors.forename: Roberto
authors.initials: R
authors.lastname: Rossotti
authors.forename: Christina
authors.initials: C
authors.lastname: Moioli
authors.forename: Clara
authors.initials: C
authors.lastname: Schiantarelli
authors.forename: Carloandrea
authors.initials: C
authors.lastname: Orcese
authors.forename: Massimo
authors.initials: M
authors.lastname: Puoti
mesh_terms: D000328:Adult; D005871:Castleman Disease / Q000175:diagnosis*; D019788:Fluorodeoxyglucose F18 / Q000008:administration & dosage*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008297:Male; D049268:Positron-Emission Tomography / Q000379:methods*; D055815:Young Adult
chemical_list: D019788:Fluorodeoxyglucose F18